TY - JOUR
T1 - Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial
AU - Nout, R. A.
AU - Smit, V. T. H. B. M.
AU - Putter, H.
AU - Juergenliemk-Schulz, Ina M.
AU - Jobsen, Jan J.
AU - Lutgens, L. C. H. W.
AU - van der Steen-Banasik, Elzbieta M.
AU - Mens, Jan Willem M.
AU - Slot, A.
AU - Kroese, Marika C. Stenfert
AU - van Bunningen, B. N. F. M.
AU - Ansink, A. C.
AU - van Putten, W. L. J.
AU - Creutzberg, C. L.
PY - 2010/3/6
Y1 - 2010/3/6
N2 - Background after surgery for intermediate-risk endometrial carcinoma, the vagina is the most frequent site of recurrence. This study established whether vaginal brachytherapy (vbt) is as effective as pelvic external beam radiotherapy (ebrt) in prevention of vaginal recurrence, with fewer adverse effects and improved quality of life.
AB - Background after surgery for intermediate-risk endometrial carcinoma, the vagina is the most frequent site of recurrence. This study established whether vaginal brachytherapy (vbt) is as effective as pelvic external beam radiotherapy (ebrt) in prevention of vaginal recurrence, with fewer adverse effects and improved quality of life.
U2 - 10.1016/S0140-6736(09)62163-2
DO - 10.1016/S0140-6736(09)62163-2
M3 - Article
SN - 0140-6736
VL - 375
SP - 816
EP - 823
JO - Lancet
JF - Lancet
IS - 9717
ER -